McDonnell, Thomas
Storrar, Joshua
Chinnadurai, Rajkumar
Heal, Calvin
Chrysochou, Constantina
Ritchie, James
Rainone, Francesco
Poulikakos, Dimitrios
Kalra, Philip
Sinha, Smeeta
Funding for this research was provided by:
Vifor Pharma (unrestricted grant, unrestricted grant, unrestricted grant)
Article History
Received: 7 August 2023
Accepted: 21 November 2023
First Online: 10 December 2023
Declarations
:
: The study complied with the declaration of Helsinki and as indicated by the NHS Health Research Authority online tool ExternalRef removed this study was not considered research requiring research ethics committee review as it was a retrospective observational study using measurements routinely collected and using fully anonymised and secondary use of data. Due to the retrospective nature of the study, the need for informed consent was waived by the ‘Research and Innovation committee of the Northern Care Alliance NHS Group’, study approval number (Ref: ID 22HIP54). This study protocol was reviewed and approved by the ‘Research and Innovation committee of the Northern Care Alliance NHS Group’, study approval number (Ref: ID 22HIP54).
: Not applicable.
: The authors declare no competing interests.